Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis.
Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, Lisak R, Miller A, Racke MK, Steinman L, Stuve O, Wiendl H, Frohman E.
Greenberg BM, et al. Among authors: frohman e, frohman t.
JAMA Neurol. 2013 Feb;70(2):248-51. doi: 10.1001/jamaneurol.2013.1017.
JAMA Neurol. 2013.
PMID: 23530268
No abstract available.